直接neodymium:YAG激光在封闭的Phakic植入式Collamer镜头端口上管理瞳孔阻塞
Xiang Ren1, Jiaying Zhang1, Nanji Lu1
1Department of Ophthalmology, Ophthalmic Laboratory, West China Hospital, Sichuan University, Chengdu, Sichuan, P.R. China.
Journal of refractive surgery (Thorofare, N.J. : 1995)
|March 7, 2026
概括
:YAG (Nd:YAG) 激光成功地治疗了患有可植入结膜透镜 (ICL) 的患者的瞳孔堵塞. 这种创新方法清除了中央端口的障碍,为ICL并发症提供了新的管理选项.
科学领域:
- 眼科医生 眼科 眼科
- 医疗技术 医疗技术 医学技术
背景情况:
- 植入可植入的粘膜透镜 (ICL) 植入是一种常见的折射手术程序.
- 瞳孔阻塞是ICL手术后的潜在并发症,导致眼内压力增加.
- 阻塞ICL的中央端口可以阻碍水性流.
研究的目的:
- 报告使用:YAG (Nd:YAG) 激光首次成功治疗ICL诱导的瞳孔阻塞.
- 为了证明Nd:YAG激光在清除中枢端口阻塞的有效性,在一个患有植入式粘合器镜头的患者中.
主要方法:
- 使用案例报告和文献审查方法.
- 前段光连贯断层扫描 (AS-OCT) 和超声生物显微镜 (UBM) 用于诊断.
- 新:YAG (Nd:YAG) 激光直接应用于ICL端口的膜阻塞.
主要成果:
- 一名25岁的女性患者在ICL植入后两个月内出现了瞳孔阻塞,眼内压升高 (47毫米升).
- 诊断成像证实了瞳孔堵塞和膜状结构阻碍了ICL的中央端口.
- Nd:YAG激光治疗无故障进行,成功消除了瞳孔阻塞.
结论:
- 这一案例是首次将 Nd:YAG 激光直接应用到一个被封闭的 phakic 眼内透镜口,以控制瞳孔阻塞.
- Nd:YAG激光治疗是一种有效的治疗选择,用于管理ICL患者的瞳孔阻塞.
- 这种技术扩大了眼科医生可用于ICL相关并发症的管理策略.
更多相关视频
04:59Author Spotlight: Enhancing Visual Outcomes in Cataract Surgery: A Novel Technique to Prevent Posterior Capsular Opacification Through IOL Rotation
Published on: July 7, 2023
3.1K
06:23Development of a Noninvasive, Laser-Assisted Experimental Model of Corneal Endothelial Cell Loss
Published on: April 24, 2020
5.9K
相关概念视频
Angle Closure Glaucoma: Treatment
1.5K
Angle-closure glaucoma, or closed-angle glaucoma, is an eye condition where the iris bulges out and blocks the iridocorneal angle, resulting in a buildup of aqueous humor and increased intraocular pressure. Immediate medical attention is necessary due to the sudden onset of symptoms. The treatment for angle-closure glaucoma includes short-term and long-term approaches. Short-term treatment involves using eye drops like pilocarpine to lower intraocular pressure by increasing aqueous humor...
1.5K
Open Angle Glaucoma: Treatment
1.1K
In open-angle glaucoma, the iridocorneal angle remains open, but the trabecular meshwork becomes stiff, slowing down the outflow of aqueous humor. This causes a buildup of aqueous humor in the anterior chamber, leading to a sudden increase in intraocular pressure. The treatment for open-angle glaucoma focuses on reducing the elevated intraocular pressure by either decreasing the secretion of aqueous humor or increasing its outflow.
Drugs such as carbonic anhydrase inhibitors, α2- and...
Drugs such as carbonic anhydrase inhibitors, α2- and...
1.1K
Glaucoma: Overview
1.6K
Glaucoma is an eye condition characterized by increased intraocular pressure that damages the retina and optic nerve, leading to irreversible blindness if left untreated. The human eye has various components, including the cornea, iris, pupil, lens, and optic nerve. Aqueous humor is secreted by the epithelium of the ciliary body in the posterior chamber and flows through the trabecular meshwork and canal of Schlemm, maintaining normal intraocular pressure. The trabecular meshwork and the canal...
1.6K
Ophthalmic Drug Delivery Systems
126
Ophthalmic drug delivery faces major limitations due to poor absorption across the corneal membrane. This process is primarily driven by diffusion and is influenced by two main factors: the physicochemical properties of the drug and tear drainage. Most ophthalmic drugs, such as pilocarpine, epinephrine, atropine, and local anesthetics, are weak bases. They are typically formulated at an acidic pH to enhance chemical stability. However, this leads to high ionization, reducing their ability to...
126
